Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity.
Benjamin O AdegbiteMatthew H AbramsonVictoria GutgartsFlorin M MusteataKinsuk ChauhanAlecia N MuwongeKristin A MeliambroSteven P SalvatoreSebastian El Ghaity-BeckleyMarina KremyanskayaBridget MarcellinoJohn O MascarenhasKirk N CampbellLili ChanSteven G CocaEllin M BermanEdgar A JaimesEvren U AzelogluPublished in: Clinical journal of the American Society of Nephrology : CJASN (2023)
Exposure to dasatinib is associated with a significant chance of developing proteinuria compared to other similar tyrosine kinase inhibitors.
Keyphrases